The fate of bezafibrate, carbamazepine, ciprofloxacin and clarithromycin in the wastewater treatment process

Revitt, D. Mike, Tuckwell, Rebecca, Garelick, Hemda ORCID logoORCID: https://orcid.org/0000-0003-4568-2300, Jones, Huw ORCID logoORCID: https://orcid.org/0000-0003-0024-864X and Lundy, Lian ORCID logoORCID: https://orcid.org/0000-0003-1155-4132 (2017) The fate of bezafibrate, carbamazepine, ciprofloxacin and clarithromycin in the wastewater treatment process. Proceedings of the 14th IWA/IAHR International Conference on Urban Drainage. In: 14th IWA/IAHR International Conference on Urban Drainage, 10-15 Sept 2017, Prague, Czech Republic. . [Conference or Workshop Item]

[img]
Preview
PDF - Final accepted version (with author's formatting)
Download (357kB) | Preview

Abstract

The progress of four pharmaceuticals (bezafibrate, carbamazepine, clarithromycin and ciprofloxacin) is followed through the treatment stages (screened sewage, settled sewage and final effluent) of a large urban wastewater treatment plant (WWTP) employing activated sludge treatment. Concentrations at the inlet to the WWTP are generally higher than those predicted from consideration of local pharmaceutical consumption and typical excretion data. Percentage removal efficiencies are variable (22.5 – 94.3%) with carbamazepine being the most resistant to elimination.

Item Type: Conference or Workshop Item (Paper)
Research Areas: A. > School of Science and Technology > Natural Sciences
Item ID: 22636
Useful Links:
Depositing User: Mike Revitt
Date Deposited: 11 Oct 2017 14:55
Last Modified: 20 Jun 2022 16:52
URI: https://eprints.mdx.ac.uk/id/eprint/22636

Actions (login required)

View Item View Item

Statistics

Activity Overview
6 month trend
83Downloads
6 month trend
388Hits

Additional statistics are available via IRStats2.